Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
ACS Macro Letters|June 2, 2022
Versatile Synthesis of Polymer-Temozolomide ConjugatesMatthew Skinner, Sarah M Ward, Todd EmrickMolecular Pharmaceutics|October 26, 2018
Polymer-Temozolomide Conjugates as Therapeutics for Treating GlioblastomaSarah M Ward, Matthew Skinner, Banishree Saha, et al.ACS Chemical Neuroscience|June 9, 2017
Augmenting Glioblastoma Chemotherapy with PolymersMatthew Skinner, Sarah M Ward, Carol L Nilsson, et al.ACS Applied Materials & Interfaces|July 22, 2015
Elastomeric Polymer Multilayer Thin Film with Sustainable Gas Barrier at High StrainFangming Xiang, Tara M Givens, Sarah M Ward, et al.ACS Macro Letters|May 25, 2022
Super Stretchy Polymer Multilayer Thin Film with High Gas BarrierFangming Xiang, Sarah M Ward, Tara M Givens, et al.Soft Matter|December 19, 2014
Structural tailoring of hydrogen-bonded poly(acrylic acid)/poly(ethylene oxide) multilayer thin films for reduced gas permeabilityFangming Xiang, Sarah M Ward, Tara M Givens, et al.The Journal of Biological Chemistry|September 24, 2010
The transcriptional repressor ID2 can interact with the canonical clock components CLOCK and BMAL1 and mediate inhibitory effects on mPer1 expressionSarah M Ward, Shanik J Fernando, Tim Y Hou, et al.Biochemical Society Transactions|July 24, 2012
Tau oligomers and tau toxicity in neurodegenerative diseaseSarah M Ward, Diana S Himmelstein, Jody K Lancia, et al.Evolutionary Applications|January 9, 2015
Interspecific hybridization transfers a previously unknown glyphosate resistance mechanism in Amaranthus speciesTodd A Gaines, Sarah M Ward, Bekir Bukun, et al.Pharmacology & Therapeutics|July 14, 2012
Tau as a therapeutic target in neurodegenerative diseaseDiana S Himmelstein, Sarah M Ward, Jody K Lancia, et al.Pageof 2